In 1994, 6000 prescriptions for methylphenidate (MPH) were made to children and
teenagers in the UK. By 1997, the rate had increased by a factor of fi fteen to 92 000 …

Background Methylphenidate (MPH) is the most common drug treatment of attention
deficit/hyperactivity disorder (ADHD) in children. Treatment with MPH is contraindicated in …

Objectives: Prescription rates of methylphenidate (MPH) are sharply rising in most Western
countries. Although it has been reported that MPH has abuse potential, little is known about …

To compile an inventory of European healthcare databases with potential to study long-term
effects of methylphenidate (MPH) in patients with attention deficit hyperactivity disorder …

English Methylphenidate (MPH) is mainly used for treatment of the attention-deficit
hyperactivity syndrome (ADHS). Non-medical use of methylphenidate as recreational drug …

Methylphenidate is primarily used for attention deficit hyperactivity disorder (ADHD) in
children. The primary aim of the study was to investigate the prescribing patterns of …

Background and objective: Sales figures have indicated that there has been a steady
increase in the use of methylphenidate in South Africa. The primary aim of the study was to …

Introduction Methylphenidate is a piperidine derivative structurally and pharmacologically
similar to amphetamine. Methylphenidate is indicated for Attention Deficit Hyperactivity …

Objectives: This paper deals with the methylphenidate (MPH) misuse by adults in Germany.
Results of a survey among primary care physicians/internists have been supplemented by a …

Abstract In December 2009, Korean regulatory agency announced that methylphenidate, a
drug used to treat attention deficit-hyperactivity disorder (ADHD), should not be used in …